Korea Investment Corp Bei Gene, Ltd. Transaction History

Korea Investment Corp

$41.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$131.8 - $202.24 $421,760 - $647,168	-3,200 Reduced 17.02%	15,600 $2.1 Million
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $1.39 Million - $2.49 Million	-11,507 Reduced 37.97%	18,800 $3.04 Million
Q1 2022 May 13, 2022	SELL	$146.52 - $269.56 $196,922 - $362,288	-1,344 Reduced 4.25%	30,307 $5.72 Million
Q4 2021 Feb 09, 2022	BUY	$248.56 - $389.34 $4.69 Million - $7.34 Million	18,851 Added 147.27%	31,651 $8.58 Million
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $549,120 - $886,908	-2,200 Reduced 14.67%	12,800 $4.65 Million
Q2 2021 Aug 12, 2021	SELL	$292.75 - $367.01 $526,950 - $660,618	-1,800 Reduced 10.71%	15,000 $5.15 Million
Q1 2021 May 13, 2021	SELL	$260.64 - $382.12 $130,320 - $191,060	-500 Reduced 2.89%	16,800 $5.85 Million
Q4 2020 Feb 10, 2021	SELL	$221.31 - $316.61 $4.03 Million - $5.76 Million	-18,200 Reduced 51.27%	17,300 $4.47 Million
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $662,130 - $1 Million	3,500 Added 10.94%	35,500 $10.2 Million
Q2 2020 Aug 12, 2020	SELL	$123.9 - $195.41 $693,840 - $1.09 Million	-5,600 Reduced 14.89%	32,000 $6.03 Million
Q1 2020 May 14, 2020	BUY	$121.84 - $173.19 $97,472 - $138,552	800 Added 2.17%	37,600 $4.63 Million
Q4 2019 Feb 11, 2020	BUY	$115.78 - $208.34 $1.09 Million - $1.96 Million	9,400 Added 34.31%	36,800 $6.1 Million
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $84,427 - $103,803	700 Added 2.62%	27,400 $3.36 Million
Q2 2019 Aug 12, 2019	SELL	$113.99 - $146.86 $330,571 - $425,894	-2,900 Reduced 9.8%	26,700 $3.31 Million
Q1 2019 May 15, 2019	SELL	$122.82 - $151.83 $356,178 - $440,307	-2,900 Reduced 8.92%	29,600 $3.91 Million
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $1.25 Million - $2.05 Million	11,700 Added 56.25%	32,500 $4.56 Million
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $30,524 - $37,932	200 Added 0.97%	20,800 $3.58 Million
Q2 2018 Aug 13, 2018	SELL	$152.5 - $216.77 $15,250 - $21,677	-100 Reduced 0.48%	20,600 $0
Q1 2018 May 09, 2018	BUY	$97.41 - $177.22 $2.02 Million - $3.67 Million	20,700 New	20,700 $3.48 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.89 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.15 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$927 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$891 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$664 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account